company background image
BST logo

Biotechnology Assets BME:BST Stock Report

Last Price

€0.34

Market Cap

€21.5m

7D

-5.6%

1Y

-11.3%

Updated

22 Jul, 2024

Data

Company Financials

Biotechnology Assets, S.A.

BME:BST Stock Report

Market Cap: €21.5m

BST Stock Overview

Develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally.

BST fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Biotechnology Assets, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biotechnology Assets
Historical stock prices
Current Share Price€0.34
52 Week High€0.50
52 Week Low€0.31
Beta1.41
11 Month Change-0.59%
3 Month Change-2.03%
1 Year Change-11.32%
33 Year Change-32.60%
5 Year Change-83.95%
Change since IPO-85.72%

Recent News & Updates

Is Biotechnology Assets (BME:BST) Using Too Much Debt?

Apr 19
Is Biotechnology Assets (BME:BST) Using Too Much Debt?

Recent updates

Is Biotechnology Assets (BME:BST) Using Too Much Debt?

Apr 19
Is Biotechnology Assets (BME:BST) Using Too Much Debt?

Is ADL Bionatur Solutions (BME:ADL) Using Too Much Debt?

Nov 17
Is ADL Bionatur Solutions (BME:ADL) Using Too Much Debt?

Shareholder Returns

BSTES BiotechsES Market
7D-5.6%0.3%-0.5%
1Y-11.3%-27.1%13.7%

Return vs Industry: BST exceeded the Spanish Biotechs industry which returned -27.1% over the past year.

Return vs Market: BST underperformed the Spanish Market which returned 13.7% over the past year.

Price Volatility

Is BST's price volatile compared to industry and market?
BST volatility
BST Average Weekly Movement4.4%
Biotechs Industry Average Movement7.5%
Market Average Movement3.0%
10% most volatile stocks in ES Market6.0%
10% least volatile stocks in ES Market0.7%

Stable Share Price: BST has not had significant price volatility in the past 3 months.

Volatility Over Time: BST's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of Spanish stocks.

About the Company

FoundedEmployeesCEOWebsite
195437Jaime Feced Rubiowww.biatgroup.com

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.

Biotechnology Assets, S.A. Fundamentals Summary

How do Biotechnology Assets's earnings and revenue compare to its market cap?
BST fundamental statistics
Market cap€21.48m
Earnings (TTM)€1.57m
Revenue (TTM)€3.91m

13.6x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BST income statement (TTM)
Revenue€3.91m
Cost of Revenue€450.59k
Gross Profit€3.46m
Other Expenses€1.88m
Earnings€1.57m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.025
Gross Margin88.47%
Net Profit Margin40.27%
Debt/Equity Ratio62.7%

How did BST perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.